[1]
“The Efficacy of Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration”, Cent Asian J Med Sci, vol. 8, no. 4, pp. 251–257, Dec. 2022, doi: 10.24079/cajms.2022.12.007.